Farshad Hasanzadeh KiabiI; Aria SoleimaniI; Mohammad Reza HabibiI
DOI: 10.21470/1678-9741-2018-0263
ABSTRACT
Introduction: The true influence of the low mean arterial pressure (low MAP) during coronary artery bypass grafting (CABG) on the development of postoperative cognitive deficit (POCD) remains controversial. We aimed to perform a meta-analysis and meta-regression to determine the effect of low MAP on POCD, as well as moderator variables between low MAP and POCD.AUC = Area under the curve
CABG = Coronary artery bypass grafting
CI = Confidence interval
CV = Coefficient of variation
CPB = Cardiopulmonary bypass
DM = Diabetes mellitus
HTN = Hypertension
MAP = Mean arterial pressure
MHRR = Mantel-Haenszel risk ratio
OR = Odds ratio
POCD = Postoperative cognitive deficit
RCTs = Randomized controlled trials
rLVEF = Reduced left ventricle ejection fraction
RR = Risk ratio
SD = Standard deviation
WAIS = Wechsler Adult Intelligence Scale
INTRODUCTION
Postoperative cognitive deficit (POCD) has long been considered a major complication after cardiac surgery[1,2]. Microemboli are assumed to be a key factor in development of brain injury after cardiopulmonary bypass (CPB) surgery[3], but to date the root cause of POCD and relevant risk factors have been poorly differentiated[4].
Low mean arterial pressure (low MAP) has been one of the most common protocols for decreasing POCD after CPB surgery[5]. Low MAP reduces bleeding at the surgical site, the need to cardiotomy suction as well as a reduction in the embolic load[6]. Although several reviews have explored the effectiveness of low MAP in reducing POCD among CABG patients, there is certain doubt concerning estimates of MAP threshold to maintain neuroprotection against embolic load[5-10]. Pepin et al.[5] concluded that cerebral autoregulation is maintained by MAP as low as 30 mmHg in moderately hypothermic patients. Murphy et al.[6] and Riley[7] suggested that only high-risk patients may require MAP >70 mmHg including patients with advanced atherosclerotic disease of the aorta, hypertension, diabetes and the elderly. Therefore, guidelines are unable to recommend any specific measures for optimal MAP during CPB. In this regard, clinical practice guidelines for MAP management endorsed by American Society of ExtraCorporeal Technology (AmSECT) advised that the intended treatment algorithm for blood pressure management prior to CPB, including acceptable ranges for blood pressure shall be defined by the perfusion care team[11]. Although avoidance of high MAP is emphasized in the literature, no threshold MAP during CPB is recommended due to insufficient published evidence[6]. Therefore, it is necessary to explore both CPB-related and patient-related factors more precisely to determine moderator variables which play an important role in the association between low MAP and POCD.
OBJECTIVE
Due to the potential neuroprotective effect of low MAP, its routine use in anesthesiology, especially CPB surgery and the lack of strong findings from randomized controlled trials (RCTs), we aimed to perform a meta-analysis to examine the effect of low MAP on the POCD and a meta-regression to determine whether moderator variables mediate the relationship between low MAP and POCD.
METHODS
Eligibility Criteria
Only RCTs were incorporated into the current meta-analysis: 1) the population comprised CABG patients; 2) there was an intervention group of lower MAP (<80 mmHg) during CPB surgery; 3) there was a control group of higher MAP ≥80 mmHg) during CPB surgery; 4) the main outcome included POCD. We excluded from the meta-analysis studies in which the neuropsychological test battery for patients with CPB surgery to assess cognitive deficit was not administered, and RCTs published in languages other than English.
Information Sources
Web of Science, PubMed database, Scopus and the Cochrane Library (until June 2018) were searched. Reference lists of relevant articles were also searched.
Search
We conducted the search with the following terms: (“coronary artery bypass surgery” OR “cardiopulmonary bypass surgery” OR “thoracic surgery” OR “cardiovascular surgery” OR “cardiac surgery” OR CABG) AND (“cognitive dysfunction” OR “cognitive function” OR “cognitive decline” OR “neurocognitive”) AND (“perfusion pressure” OR “mean arterial pressure” OR “low* MAP” OR “high* MAP” OR “arterial pressure”) AND (“randomised controlled trial” OR “controlled clinical trial” OR “randomized” OR “randomly” OR “trial”). The reference lists of the retrieved studies were also checked, as well as meta-analyses, and systematic reviews on MAP.
Study Selection
The study selection process is detailed in Figure 1. First, titles of records were identified and duplicates were removed. Second, abstracts were screened. Third, following a full-text analysis of the selected abstracts, eligible articles were included.
Data Items
The primary endpoint was POCD in intervention and control groups. The occurrence of any cognitive deficit after CPB surgery was defined as the primary outcome (a decline >1 SD in the postoperative score in comparison to the preoperative score). The decline must be attributed to one or more neuropsychological tests. The first 30, 30 to 90, and 90 to 360 days are labelled as the very early, early, and late occurrence of cognitive deficit after CPB surgery, respectively[1]. The moderator variables including male gender (%), age (%), mean duration of CPB (minutes), mean arterial pressure (MAP), diabetes mellitus (DM) (%), hypertension (HTN) (%), follow-up period (days) and reduced left ventricle ejection fraction (rLVEF) (%) were collected.
Data Collection Process
Two independent authors extracted the data. Authors solved all disagreements by discussion and consensus. Patient demographic data, surgery characteristics and outcomes were extracted.
Risk of Bias in Individual Studies
The Jadad scale, which assesses the quality of published clinical trials based on methods relevant to random assignment, double-blinding, and patient flow, was used to assess the quality of RCTs. This scale scores a maximum of two points for each criterion (randomization and blinding) and one point for the description of withdrawals and dropouts[12]. Details of randomization, allocation concealment, blinding of participants and outcomes were detailed in Table 1. Two reviewers verified the included RCTs.
| Gold et al.[16], 1995 | Charlson et al.[17], 2007 | Siepe et al.[18], 2011 | ||||
|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | Intervention | Control | |
| MAP (mmHg) | 50-60 | 80-100 | 70-90 | 80 | 60-70 | 80-90 |
| N. of pts | 124 | 124 | 206 | 206 | 48 | 44 |
| Age, mean (SD) | 66.2 (10.1) | 65.4 (8.6) | 64.3 (13.4) | 65.2 (11.1) | 65.2 (9.6) | 68.7 (8.3) |
| Male (%) | 78 (62.9) | 82 (66.12) | 146 (71) | 146 (71) | 40 (83) | 34 (77) |
| Diabetes | 23 (18.24) | 18 (14.51) | 70 (34) | 66 (32) | 12 (25) | 10 (22) |
| Hypertension | 44 (35.48) | 56 (45.16) | 111 (54) | 115 (56) | 30 (63) | 32 (72) |
| CPB duration, min, mean (SD) | 89.4 (31.5) | 84.9 (28.3) | 77 (22) | 74 (24) | 101 (25) | 91 (30) |
| Procedure | CABG with CPB | CABG with CPB | CABG with CPB | |||
| Follow-up (days) | Before surgery, 7 and 180 days postoperatively | The day before surgery and 1-2, 5-6 and 180 days after surgery | The day before and 2 days after surgery | |||
| Dropout (%) | n=11 (4%) at 180 days - Dropouts in low MAP group: 3 refused, 1 lost, 4 moved (5 deaths) - Dropouts in high MAP group: 4 refused, 2 moved (2 deaths) |
n=11 (3.1%) at 180 days - 5 (1.5%) refused, 6 (1.6%) lost - 14 (3.4%) deaths - Not reported for each group |
n=13 (12.38%) - Dropouts in low MAP group: 4 unable to perform test, 3 additional valves repair - Dropouts in high MAP group: 5 exceeded from targeted perfusion pressure, 1 unable to perform test |
|||
| Jadad score | Total score (5): randomization (1); method of randomization (1); blinding (1); method of blinding (1); withdrawal reason (1) | Total score (4): randomization (1); blinding (1); method of blinding (1); withdrawal reason (1) | Total score (3): randomization (1); blinding (1); withdrawal reason (1) | |||
Synthesis of Results
Q and I2 were used to assess statistical heterogeneity among the selected studies. Variables with Q statistics with P-value <0.05 were considered heterogeneous. It means that the amount of total variance is more than we would expect based on within-study error, so the random effect model was assumed. Meta-regression was performed using a random-effect model because there was significant between-study variation[13]. The I2 statistics represent the degree of heterogeneity and the proportion of variation in treatment that is independent from sampling error. Moderate heterogeneity assumed as I2 was 30% to 60%[14].
Meta-Regression Analysis
The relationship between one or more moderators and a dependent variable was examined by meta-regression analysis[15]. The effect size as dependent variable and the moderator variable as independent variable were analyzed to identify potential predictors of effect size. Qmodel statistics with P-value <0.05 showed that the relationship between moderator variable and treatment effect is stronger than we would expect by chance. Variables with Z statistics with P-value <0.05 were interpreted as their slope is probably not zero, and the treatment effect is more effective when the moderator variable changes[13]. Mantel-Haenszel (MH) log risk ratio was regressed on the following variables: between-group proportion difference of male gender (%), HTN (%) and DM (%), between-group mean difference of age (years), CPB time (minutes) and MAP (mmHg). Difference was defined as the difference between high MAP and low MAP groups (high MAP-low MAP). Negative value of MH log risk ratio is in favour of the neuroprotective effect of low MAP. Data are presented as a mean (standard deviation) for continuous variables and as proportions (%) for categorical variables.
RESULTS
Study Selection
From a total of 142 citations identified, 18 articles were reviewed in depth. Three studies (RCTs) with a total of 731 patients were included in the final analyses[16-18]. The search strategy is shown in Figure 1.
Study Characteristics
All studies had an above moderate score on the Jadad scale; two studies had a high score (Table 1). Among RCTs, the most commonly used scale to examine the severity of cognitive deficit was the Wechsler Adult Intelligence Scale (WAIS). The overall incidence was 6.40% for POCD. The incidence of POCD was 6.37% and 6.44% for low MAP and high MAP groups, respectively. The female patients' frequency was lower than that of male patients in all RCTs. The mean CPB time ranges from 74 to 101 minutes. Also the mean time difference between low MAP and high MAP groups is up to 10 minutes. The proportion of patients with diabetes varied widely (16.5% to 33%), as did the range of patients with hypertension (40.32% to 67.39%). There was no significant difference between the low MAP and the high MAP groups in relation to the baseline characteristics of patients in all RCTs. The primary characteristics of the eligible studies were presented in Table 1. Their data and conclusions are summarized in Table 2.
| Study | Design | Trial procedure | NP test | Endpoint | Conclusion |
|---|---|---|---|---|---|
| Gold et al. [16], 1995 | Parallel groups, randomized, prospective, double-blind trial | - High MAP (80-100)
vs. low MAP (50-60) - The alpha-stat protocol 17 for blood gas management was used, and body temperature was cooled to 28°C to 30°C. If MAP increased above the target level and was unresponsive to fentanyl or midazolam, sodium nitroprusside infusion was administered. If MAP fell below the target level, phenylephrine was used. If necessary, norepinephrine or metaraminol were added |
- Wechsler adult intelligence scale
(WAIS-R) - Trail Making A and B - Grooved pegboard test (Pegs) - Boston Naming, Benton Visual Retention and Recognition Test - Controlled Oral Word Association - Mattis-Kovner Verbal Recall and Recognition, and Finger-Tapping Test - Ammons Quick Test - Control tests: CES-D and SF-36 Health Survey |
- A decline determined a
priori by a panel of experts in the postoperative
score in comparison to the preoperative score - POCD if occurred in three or more tests |
- Higher MAP during CPB can effectively improve outcomes after coronary bypass |
| Charlson et al.[17], 2007 | Parallel groups, prospective, randomized, and double-blinded | - High MAP (80) vs.
custom MAP (≤90) - In the high MAP group: if MAP was low, a phenylephrine bolus of 5-15 mcg/kg was given to return MAP to the usual usage range; infusions of 10 mg/250 cc phenylephrine were also used, if necessary. If this was inadequate to maintain MAP, norepinephrine and/or metarainol infusions were given. If MAP was above the target MAP, nitroglycerin 1 mcg/kg bolus was given followed by an infusion of 0.5-20 mcg/kg/min as needed. If this was inadequate, sodium nitroprusside 1-15 mcg/kg/min was infused. In the custom group: patients had pressure maintained during full flow in their custom MAP using the same vasoactive drugs employed in the high MAP group |
- Wechsler Adult Intelligence Scale
(WAIS-R) - Trail Making A and B - Grooved pegboard test (Pegs) - Boston Naming, Benton Visual Retention and Recognition Test - Controlled Oral Word Association - Mattis-Kovner Verbal Recall and Recognition, and Finger-Tapping Test - Ammons Quick Test - Control tests: CES-D and SF-36 Health Survey |
- A decline determined a
priori by a panel of experts in the postoperative
score in comparison to the preoperative score - POCD if occurred in three or more tests |
- There were no statistically
significant differences between the high MAP group and the custom MAP group for cognitive complications |
| Siepe et al. [18], 2011 | Parallel groups, prospective, randomized, and double-blinded | - High MAP (80-90)
vs. low MAP (60-70) - Arterial hypertension with norepinephrine (maximal dose 0.4 mg/kg/min) and hypotension with single 5-mg bolus of urapidil (maximal dose 0.1 mg/kg/min) |
- Mini-Mental-State Examination (MMSE) | - Any score of 10 points under the preoperative score, together with a positive assessment by a psychologist, was considered delirium tests | Maintenance of perfusion pressure at physiologic levels during normothermic CPB (80-90 mmHg) is associated with less early POCD and delirium |
Synthesis of Results
The overall effect of low MAP was determined by meta-analysis. The MHRR was calculated for the effect of low MAP on POCD as 1.012 (95% CI: 0.277-3.688). The MHRRs for very early and late cognitive deficit were 11.939 (95% CI: 0.692-205.945) and 0.681 (95% CI: 0.239-1.939) (Figure 2). The findings of the pooled analyses, as well as the heterogeneity of the studies, which was found to be 66.57% in total, were summarized in Figure 2.
Meta-regression Analysis
A meta-regression analysis was performed to determine the overall effect of moderator variables. The MH log RR was calculated for age as 1.281 (95% CI: 0.187-2.375); Z-value: 2.296, P-value: 0.021, Qmodel: 5.273, df: 1, P-value: 0.021 (Figure 3A). Figure 3 shows that increasing age is related to a higher occurrence of POCD in the low MAP group. The MH log RR was calculated for between-group CPB time difference as -0.519 (95% CI: -0.949 - -0.089); Z-value: -2.367, P-value: 0.017, Qmodel: 5.603, df: 1, P-value: 0.017 (Figure 3B). Figure 3 shows that a lower occurrence of POCD is associated with shorter CPB time in each study, which means that prolonged CPB time in low MAP groups significantly confused the comparison of neuroprotective effect of the studies. Other moderator variables, such as gender, HTN, DM and loss to follow-up, were not significant.
Risk of Bias Across Studies
A funnel plot for publication bias analysis is not recommended with less than 10 studies, so it is not shown here[19]. Only one of the included studies reported that MAP ranged from 57 to 90 mmHg in the low MAP group[17]. In the study by Charlson et al.[17], the MAP target has been set by the pre-bypass MAP in the low MAP group, so patients did not receive MAP higher than baseline MAP during CPB. In high MAP group, MAP kept fixed at 80 mmHg and therefore, no one in high MAP group received MAP <80 mmHg. In contrast, several patients received MAP as low as 57 mmHg in low MAP group. Therefore, it is reasonable to assign patients without hypotension to the high MAP group.
Sensitivity Analysis
‘‘Remove-One’’ sensitivity analysis showed that there was no significant association between low MAP and POCD (P<0.43) after the exclusion of Charlson et al.[17] study, meaning that overall effect was not biased by the excluded study. In fact, there are no influential studies in any of the analyses based on ‘‘Remove-One’’ sensitivity analysis. In addition, CPB difference for Gold et al. was (-4.5 min) and (-10 min) for Siepe et al.[18] study. CPB difference was (-3 min) for Charlson et al.[17], which is between the values for Siepe et al.[18] and Gold et al.[16], so Charlson et al.[17] could not be a source of bias in meta-regression of CPB time difference on MH log RR (Figure 3B).
DISCUSSION
Summary of Evidence
This is the first meta-regression of the effectiveness of low MAP in reducing POCD after CPB surgery, demonstrating that shorter CPB time had a favorable influence in significantly reducing POCD after CPB surgery. This finding may have critical implications for the therapeutic management of patients undergoing CABG surgery[1].
The Role of Low MAP
It is routine to keep MAP at a level below the physiological threshold around 50 mmHg[6,19]. In most patients, maintaining a sufficient pump flow in the 50 mmHg range does not require any further interventions during CPB[18]. The blood supply to the brain is relatively constant because cerebral autoregulation works during CPB when managed either by alpha-stat or pH-stat[20]. It is believed that high MAP increases cerebral embolic load as well as the risk of brain injury[21]. High MAP results in high CBF, which may increase cerebral embolic load and cerebral edema as well[22]. The increasing number of patients with high-risk criteria have raised concerns about the possible indication of high MAP during CPB[6,7]. Patients with atherosclerosis of the aorta, hypertension, diabetes, previous stroke and age >70 years are at high risk for POCD[19].
Ono et al.[20] showed that keeping blood pressure below the level of autoregulation is significantly associated with increased morbidity and mortality after cardiac surgery (OR: 1.36; 95% confidence interval: 1.08-1.71; P=0.008). The AUC (area under the curve) for low MAP was greater for patients with high morbidity or mortality than for those without (6.5 vs. 2.4 mmHg × min/h). They also showed that average MAP during CPB for patients with high morbidity or mortality is not significantly different (75 vs. 74 mmHg) from those for patients without high morbidity or mortality. It is worth mentioning, however, that average MAP did not differ between groups, patients with higher morbidity and mortality had significantly longer CPB duration times (133 vs. 106 min)[20], implying that CPB time as well as low MAP is strongly associated with morbidity and mortality as well.
In line with other reviews[5-7], meta-analysis showed that low MAP does not reduce POCD after CABG surgery. However, there is no statistically significant difference between the two groups, the incidence of POCD for very early and late was 6.52 and 4.98, respectively, showing that the trend is consistent with that of reported by Brown et al.[3]. They found that there is a logarithmic reduction in the frequency of microemboli as well as the embolic load through days spent after CPB (especially in the first few days after CPB surgery). In our study, there is a trend toward lower occurrence of POCD in the low MAP group (6.37% vs. 6.44%), suggesting that a confounding variable may interfere with a significant reduction in the occurrence of POCD in the low MAP group. In search of confounding factors that can influence the occurrence of POCD, we further performed meta-regression of moderator variables. Meta-regression analysis showed that there was a significant association between moderators (CBP time difference and age) and POCD.
The Role of CPB Surgery Time
Meta-regression analysis demonstrated that shorter CPB time is related to a lower rate of POCD in either group, suggesting that CPB time is an independent predictor of POCD. In the regression model, patients with longer surgery time had a significantly increased risk for the occurrence of POCD regardless of the type of group. Bearing in mind that no study had a shorter surgery time for the low MAP group, it may explain why the studies' findings have been inconclusive across all previous reviews. Figure 3 shows that the protective effect of low MAP can only resist up to 4 minutes of longer mean duration of high MAP. Other studies also support this finding, implying that prolonged CPB time is related to an increasing embolic load[3,23]. The pivotal role of surgery time in CABG patients has fully been understood in the literature[23-25]. Brown et al.[3] reported that each 60-minute increase in CPB time associates with 30.5% increase in the embolic burden. This increase is more severe in patients with valve repair surgery (145.3% per hour). In this line, a multivariate analysis showed even 30-minute increments in CPB time acts as an independent risk factor for postoperative death significantly (OR=1.57)[26]. Bucerius et al.[27] indicated that CPB time longer than 2 hours should also be considered as an independent risk factor for stroke (OR=1.42). Therefore, it is implied that the final outcomes after CABG surgery are significantly associated with CPB time. Mean CPB time varied between 74 and 101 minutes and the absolute mean CPB time difference between high MAP and low MAP groups is up to 10 minutes in the present study. However, there was no significant difference in mean CPB time between groups in all RCTs; low MAP groups had experienced greater mean CPB time in all studies[16-18]. So probably the great impact of prolonged CPB time on emboli formation interfered with the neuroprotective effect of low MAP. In addition, we should bear in mind that mean statistics can be highly affected by extreme values and are not appropriate statistics for highly skewed distributions. An analysis of 5,000 patients undergoing CABG showed that the distribution of CPB duration is positively skewed (0.18) and data is dispersed (coefficient of variation=40%), showing that 25% of surgeries lasted longer than 135 minutes (up to 643 minutes)[26]. In this study, each 30-minute increment in CPB time increased 1.53 times the risk of death, so it implies that final outcomes, such as death, stroke, POCD, are very sensitive to CPB time. In the RCTs included in our review, coefficient of variation (CV) of CPB time is mainly between 20 to 30%, implying that there is considerable dispersion in data. It is also clear that mean statistics is not a valid estimate of skewed data, while dispersed cases have a strong association with the final outcomes. Therefore, dispersity may be responsible for the fact that the neuroprotective effect of low MAP is not significant in the meta-analysis. It is suggested that insignificant difference between mean CPB time is not enough to compare the occurrence of POCD between groups, so patients also need to be stratified for the CPB time.
The Role of Age
Increasing age is associated with a higher occurrence of POCD in the low MAP group, based on the meta-regression analysis. Patients may benefit more from high MAP protocol as they age. On the other hand, low MAP protocol did not offer any advantage over the high MAP group. The result must be interpreted carefully, because the mean age varied between 64.75 and 66.87 years among studies (mean difference: 2.12 years). This finding is supported by other studies showing that elderly may need high MAP during CPB[6,7,19]. However, a multivariable linear regression revealed that MAP was unrelated to POCD, and interactions between age and MAP area less than 50 mm Hg were significant, meaning that hypotension contributed significantly to POCD in the elderly[28].
The Role of Follow-up Period
Cognitive status has been assessed in different time periods in the studies (2 days and 6 months). The follow-up period ranges from 2 days after cardiac surgery to 6 months in the current RCTs. Most studies have reported that the highest rates of POCD occurred during the first weeks following CABG surgery. It was also followed by a significant decline in the incidence rate in the first 6 months[3,29,9,30]. Cormack et al. demonstrated a pattern developed for reduction in POCD across all four measures in the first year after CPB surgery[1]. They also reported that there is a decline in half of the routinely used tests in the first week after CPB surgery, specifically in measures that assess psychomotor function[1]. Moreover, the practice effect indicates that the results of patients with POCD may be confounded by the results of patients who showed practice effects over multiple testing sessions[2]. However, the improvement in the declining trend in POCD after CABG surgery may be originated from the learning effect. Brown et al. reported that as time passes after CPB, a consistent reduction in the number of microemboli is seen[3], which means that there may be another explanation for the declining trend in POCD.
The Possible Role of Confounders
Some part of discrepancy among studies may come from the variability in the definition of POCD[31]. However, Gold et al.[16] and Charlson et al.[17] used a cognitive decline determined a priori by a panel of experts in the postoperative score in comparison to the preoperative score that might be different from the commonly used criteria in other neurocognitive studies (1 SD decline). One SD decline in the postoperative score in comparison to the preoperative score is the most commonly used measure to define POCD in the literature. A fixed amount of decline for each patient is used exclusively in this criterion. Mahanna et al.[31] found that this criterion estimates between the higher (20% drop) and lower impairment index rating estimates of cognitive decline. Therefore, one SD decline criterion may miss up to 30% of the occurrence of POCD in both groups[31]. Finally, the both low and high MAP groups have randomly been assigned, so this discrepancy may not be recognized as a source of bias between groups. Cognitive testing is still considered as the cornerstone for POCD measurement in the light of limitation of POCD definition. In addition, Gold et al.[16] and Charlson et al.[17] defined POCD if occurred in three or more tests; that is clearly distinct from that of most of the research conducted in neurocognitive assessment (in one or more tests)[2]. Therefore, the result must be interpreted cautiously because the neurocognitive criteria are strict.
Patients lost to follow-up ranged from 3.1% to 12.38% in the present study. Meta-regression analysis revealed a significant association between the occurrence of POCD among RCTs and loss to follow-up (MH log RR: 0.358, 95% CI: 0.030-0.687, Z-value 2.138, P-value=0.032). Loss to follow-up in Siepe et al.[18] was 12.38% in very early assessment. The validity of studies in which more than 20% of patients are lost to follow-up is questionable[32]. After exclusion of the study of Siepe et al.[18], there was also no significant association between low MAP and POCD. It is worth mentioning that MHRR decreased from 1.012 to 0.681 in favor of low MAP insignificantly. In current studies, the rate of loss to follow-up is not significantly different between groups in order to lessen the bias caused by a notable dropout rate.
There may be multiple factors contributing to POCD, but very few of them have been proven to have the remarkable effect on cognitive deficit as much as CPB time. CABG surgery with valve repair may put patients as a greater risk for the occurrence of POCD than isolated CABG surgery[3]. All RCTs excluded valve repair, so it is not a concern in the current meta-analysis. Comparison of on- and off-pump among patients in CABG groups has not shown significant differences in the occurrence of POCD. In this way, a meta-analysis revealed that there is no significant protective effect for off-pump CABG[33,10]. On-pump CABG surgery is used in all RCTs, so surgery technique may not confound the results.
Limitations of the Present Study
Several limitations may be considered for this meta-analysis. The studies have been conducted from 1995 to 2011, so did not succeed to contact authors to access the raw data. The skewness of CPB time would be calculated if we had access to median CPB time. The effect of low MAP on cognitive deficit after CPB surgery with focus on CPB time deserves further investigation and it is necessary to conduct homogeneous follow-up timing and consensual definition of cognitive deficit.
However, Turner et al.[34] argued that when at least two adequately powered studies are available in meta-analysis, underpowered studies often contribute little information, so the result is reliable. Large multicenter, randomized studies are needed to provide additional data.
CONCLUSION
Meta-analysis showed that POCD must be considered as a common event among CABG patients. Older patients may benefit less from low MAP. The neuroprotective effect of low MAP on POCD was attenuated by the prolonged CPB time. Shorter CPB time is related to a lower occurrence of POCD. Low MAP may decrease the risk of POCD after CABG surgery if CPB time stratified rigorously between low MAP and high MAP patients.
REFERENCES
1. Cormack F, Shipolini A, Awad WI, Richardson C, McCormack DJ,Colleoni L, et al. A meta-analysis of cognitive outcome following coronaryartery bypass graft surgery. Neurosci Biobehav Rev. 2012;36(9):2118-29.doi:10.1016/j.neubiorev.2012.06.002.
2. Gholipour Baradari A, Habibi MR, Habibi V, Nouraei SM.Administration of lidocaine to prevent cognitive deficit in patients undergoingcoronary artery bypass grafting and valve plasty: a systematic review andmeta-analysis. Expert Rev Clin Pharmacol. 2017;10(2):179-85.doi:10.1080/17512433.2017.1266252. [MedLine]
3. Brown WR, Moody DM, Challa VR, Stump DA, Hammon JW. Longer durationof cardiopulmonary bypass is associated with greater numbers of cerebralmicroemboli. Stroke. 2000;31(3):707-13.doi:10.1161/01.STR.31.3.707.
4. Haddock CK, Poston WS, Taylor JE. Neurocognitive sequelae followingcoronary artery bypass graft. A research agenda for behavioral scientists. BehavModif. 2003;27(1):68-82. doi:10.1177/0145445502238694. [MedLine]
5. Pepin E, Dulan S. Effects of mean arterial pressure on cerebralperfusion during cardiopulmonary bypass: a review. J Extra Corpor Technol.2003;35(4):297-303. [MedLine]
6. Murphy GS, Hessel EA 2nd, Groom RC. Optimal perfusion duringcardiopulmonary bypass: an evidence-based approach. Anesth Analg.2009;108(5):1394-417. doi:10.1213/ane.0b013e3181875e2e.
7. Riley JB. Mean arterial blood pressure during cardiopulmonarybypass. J Extra Corpor Technol. 2013;45(3):195-7.
8. Licker M, Diaper J, Cartier V, Ellenberger C, Cikirikcioglu M,Kalangos A, et al. Clinical review: management of weaning from cardiopulmonarybypass after cardiac surgery. Ann Card Anaesth. 2012;15(3):206-23.doi:10.4103/0971-9784.97977.
9. Patel N, Minhas JS, Chung EM. Risk factors associated with cognitivedecline after cardiac surgery: a systematic review. Cardiovasc PsychiatryNeurol. 2015;2015:370612. doi:10.1155/2015/370612.
10. Fink HA, Hemmy LS, MacDonald R, Carlyle MH, Olson CM, Dysken MW, etal. Cognitive outcomes after cardiovascular procedures in older adults: asystematic review . Rockville (MD): Agency for Healthcare Research andQuality (US); 2014 . Available from
11. Standards and Guidelines For Perfusion Practice . AmericanSociety of ExtraCorporeal Technology. 2017 . Available from:
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, GavaghanDJ, et al. Assessing the quality of reports of randomized clinical trial: isblinding necessary? Control Clin Trials. 1996;17(1):1-12.doi:10.1016/0197-2456(95)00134-4. [MedLine]
13. Borenstein M, Hedges L, Higgins J, Rothstein H. Meta-regression. Introduction to meta-analysis. 2009:187-203. doi:10.1002/9780470743386.ch20.
14. Tarsilla M. Cochrane handbook for systematic reviews of interventions. J Multidiscip Eval 2010; 6:142-8.
15. Mirhaghi A, Mazlom R, Heydari A, Ebrahimi M. The reliability of the Manchester Triage System (MTS): a meta-analysis. J Evid Based Med. 2017;10(2):129-35. doi:10.1111/jebm.12231.
16. Gold JP, Charlson ME, Williams-Russo P, Szatrowski TP, Peterson JC, Pirraglia PA, et al. Improvement of outcomes after coronary artery bypass: a randomized trial comparing intraoperative high versus low mean arterial pressure. J Thorac Cardiovasc Surg. 1995;110(5):1302-14; discussion 1311-4. doi:10.1016/S0022-5223(95)70053-6.
17. Charlson ME, Peterson JC, Krieger KH, Hartman GS, Hollenberg JP, Briggs WM, et al. Improvement of outcomes after coronary artery bypass II: a randomized trial comparing intraoperative high versus customized mean arterial pressure. J Card Surg. 2007;22(6):465-72. doi:10.1111/j.1540-8191.2007.00471.x. [MedLine]
18. Siepe M, Pfeiffer T, Gieringer A, Zemann S, Benk C, Schlensak C, et al. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011;4091):200-7. doi:10.1016/j.ejcts.2010.11.024.
19. Grogan K, Stearns J, Hogue C. Brain protection in cardiac surgery. Anesthesiol Clin. 2008 ;26(3):521-38. doi:10.1016/j.anclin.2008.03.003. [MedLine]
20. Ono M, Brady K, Easley RB, Brown C, Kraut M, Gottesman RF, et al. Duration and magnitude of blood pressure below cerebral autoregulation threshold during cardiopulmonary bypass is associated with major morbidity and operative mortality. J Thorac Cardiovasc Surg. 2014;147(1):483-9. doi:10.1016/j.jtcvs.2013.07.069. [MedLine]
21. Hogue CW Jr, Palin CA, Arrowsmith JE. Cardiopulmonary bypass management and neurologic outcomes. An evidence-based appraisal of current practices. Anesth Analg. 2006;103(1):21-37. doi:10.1213/01.ANE.0000220035.82989.79. [MedLine]
22. Harris DN, Bailey SM, Smith PL, Taylor KM, Oatridge A, Bydder GM. Brain swelling in first hour after coronary artery bypass surgery. Lancet. 1993;342(8871):586-7. doi:10.1016/0140-6736(93)91412-F. [MedLine]
23. Utley JR, Leyland SA, Johnson HD, Morgan MS, Wilde CM, Bell MS, et al. Correlation of preoperative factors, severity of disease, type of oxygenator and perfusion times with mortality and morbidity of coronary bypass. Perfusion. 1991;6(1):15-22. doi:10.1177/026765919100600103. [MedLine]
24. Åberg T, Kihlgren M. Cerebral protection during open-heart surgery. Thorax. 1973;32(5):525-33. doi:10.1136/thx.32.5.525.
25. Kuroda Y, Uchimoto R, Kaieda R, Shinkura R, Shinohara K, Miyamoto S, et al. Central nervous system complications after cardiac surgery: a comparison between coronary artery bypass grafting and valve surgery. Anesth Analg. 1993;76(2):222-7. [MedLine]
26. Salis S, Mazzanti VV, Merli G, Salvi L, Tedesco CC, Veglia F, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22(6):814-22. doi:10.1053/j.jvca.2008.08.004. [MedLine]
27. Bucerius J, Gummert JF, Borger MA, Walther T, Doll N, Onnasch JF, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg. 2003;75(2):472-8. doi:10.1016/S0003-4975(02)04370-9. [MedLine]
28. Newman MF, Kramer D, Croughwell ND, Sanderson I, Blumenthal JA, White WD, et al. Differential age effects of mean arterial pressure and rewarming on cognitive dysfunction after cardiac surgery. Anesth Analg. 1995;81(2):236-42. doi:10.1097/00132586-199610000-00033. [MedLine]
29. van Dijk D, Keizer AM, Diephuis JC, Durand C, Vos LJ, Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg. 2000;120(4):632-9. doi:10.1067/mtc.2000.108901. [MedLine]
30. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344(6):395-402. Erratum in: N Engl J Med 2001;344(24):1876. doi:10.1056/NEJM200102083440601. [MedLine]
31. Mahanna EP, Blumenthal JA, White WD, Croughwell ND, Clancy CP, Smith LR, et al. Defining neuropsychological dysfunction after coronary artery bypass grafting. Ann Thorac Surg. 1996;61(5):1342-7. doi:10.1016/0003-4975(95)01095-5. [MedLine]
32. Dettori JR. Loss to follow-up. Evid Based Spine Care J. 2011;2(1):7-10. doi:10.1055/s-0030-1267080. [MedLine]
33. Marasco SF, Sharwood LN, Abramson MJ. No improvement in neurocognitive outcomes after off-pump versus onpump coronary revascularisation: a meta-analysis. Eur J Cardiothorac Surg. 2008;33(6):961-70. doi:10.1016/j.ejcts.2008.03.022. [MedLine]
34. Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One. 2013;8(3):e59202. doi:10.1371/journal.pone.0059202. [MedLine]
No financial support.
No conflict of interest.
Authors’ roles & responsibilities
FHK Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published
AS Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published
MRH Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; final approval of the version to be published
Article receive on Friday, August 31, 2018
Article accepted on Sunday, February 3, 2019
All scientific articles published at www.rbccv.org.br are licensed under a Creative Commons license
All rights reserved 2017 / © 2024 Brazilian Society of Cardiovascular Surgery
DEVELOPMENT BY 
English PDF
Print
Send this article by email
How to cite this article
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter